Becton Dickinson & Co (BDX): Free Cash Flow
$2.67B
Year ended 2025-09-30
+21.2%
3-year compound annual growth
+4.3%
5-year compound annual growth
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $2.67B | -14.4% | 2025-11-25, From 2024-10-01 |
| 2024-09-30 | $3.12B | +47.4% | 2025-11-25, From 2023-10-01 |
| 2023-09-30 | $2.12B | +41.3% | 2025-11-25, From 2022-10-01 |
| 2022-09-30 | $1.50B | -48.9% | 2024-11-27, From 2021-10-01 |
| 2021-09-30 | $2.93B | +35.2% | 2023-11-21, From 2020-10-01 |
| 2020-09-30 | $2.17B | n/c | 2022-11-22, From 2019-10-01 |
| No annual figure between 2015-09-30 and 2020-09-30. | |||
| 2015-09-30 | $1.13B | -1.7% | 2017-11-22, From 2014-10-01 |
| 2014-09-30 | $1.15B | -3.4% | 2016-11-23, From 2013-10-01 |
| 2013-09-30 | $1.20B | -0.9% | 2015-11-25, From 2012-10-01 |
| 2012-09-30 | $1.21B | +6.8% | 2014-11-26, From 2011-10-01 |
| 2011-09-30 | $1.13B | +6.9% | 2013-11-27, From 2010-10-01 |
| 2010-09-30 | $1.06B | n/c | 2012-11-21, From 2009-10-01 |
| 2009-09-30 | $1.07B | +5.0% | 2011-11-23, From 2008-10-01 |
| 2008-09-30 | $1.02B | n/c | 2010-11-24, From 2007-10-01 |
| 2007-09-30 | $673.66M | n/a | 2010-01-21, From 2006-10-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Becton Dickinson & Co (BDX) | 2025-09-30 | $2.67B | -14.4% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $3.66B | +38.3% |
| 3M Co (MMM) | 2025-12-31 | $1.40B | +118.8% |
| Stryker Corp (SYK) | 2025-12-31 | $4.28B | +22.8% |
| Medline Inc. (MDLN) | 2025-12-31 | $1.30B | -8.3% |
| Baxter International Inc (BAX) | 2025-12-31 | $332.00M | -42.1% |
| Solventum Corp (SOLV) | 2025-12-31 | -$10.00M | n/m |
| ResMed Inc (RMD) | 2026-06-30 | $1.65B | -0.7% |
| Dexcom Inc (DXCM) | 2025-12-31 | $1.08B | +70.8% |
Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗